// App-Quantinova.ai

: ACTIVATED AND EXPANDED NATURAL KILLER CELLS FROM MULTIPLE MYELOMA PATIENTS DESTROY TUMOR DRUG RESISTANT CELLS AND CLONOGENIC TUMOR CELLS

Researchers

Presenter

  • Alejandra Leivas

Principal Investigators

  • Inmaculada Rapado

  • Luca Fernndez

  • Antonio Prez-Martnez

  • Juan Jos Lahuerta

  • Joaqun Martnez-Lpez

Medical Centers

  • hematology,Hospital Universitario 12 de Octubre,Madrid,Spain;Hematological Malignancies Clinical Research Unit,Spanish National Cancer Research Center,Madrid,Spain

  • hematology,Hospital Universitario 12 de Octubre,Madrid,Spain;Hematological Malignancies Clinical Research Unit,Spanish National Cancer Research Center,Madrid,Spain

  • H12O-CNIO Haematological Malignancies Clinical Research Unit,Spanish National Cancer Research Centre (CNIO),Madrid,Spanien

  • Pediatric hematology, Hospital Universitario La Paz, Madrid, Spain

  • Histopathology, Hospital Universitario 12 de Octubre, Madrid, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Natural Killer cells

  • Circulating tumor cells

  • Cluster of Differentiation 34

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved